Global Sickle Cell Anemia Market Report By Treatment (Blood Transfusion, Pharmacotherapy And Bone Marrow Transplant) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026
ID:VMR11210523
February 2020
Report Formats:

As per this study the Global Sickle Cell Anemia Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.

Sickle cell anemia also is known as sickle cell disease is the type of blood disorder that affects red blood cells that leads to a reduction in their oxygen carrying capacity. Extreme tiredness or fatigueness, periodic episodes of pain, frequent infections, and vision problems are some of the common symptoms of sickle cell anemia. Some of the effective treatments to cure sickle cell anemia are stem cell transplant, pharmacology, and blood transfusion along with medication to prevent and minimize complications.
 
Market Dynamics
 
Increase in a count of the population suffering from blood-related disorders especially in underdeveloped nations is driving the demand for effective treatment. Growing awareness regarding the disease, favorable governmental initiatives and improvement in healthcare services is again boosting the market growth. Also, the rise in funding by the government towards genetic therapies to cure such diseases is further promoting the market growth. However, the high cost of treatment is likely to hinder the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of sickle cell anemia.
 
Market Segmentation
 
The broad sickle cell anemia market has been sub-grouped into treatment. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Treatment

  • Blood Transfusion
  • Pharmacotherapy
  • Bone Marrow Transplant
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for sickle cell anemia in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Sickle Cell Anemia Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the sickle cell anemia market include Bluebird Bio, Emmaus Life Sciences, Global Blood Therapeutics, Novartis and Pfizer among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Sickle Cell Anemia  Market
       2.2. Global Sickle Cell Anemia  Market Snapshot
 
3 . SICKLE CELL ANEMIA  – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Sickle Cell Anemia  Market
       3.3. Market Restraints of Sickle Cell Anemia  Market
       3.4. Opportunities of Sickle Cell Anemia  Market
       3.5. Trends of Sickle Cell Anemia  Market
       3.6. Porter’s Five Force Analysis of Sickle Cell Anemia  Market
       3.7. Sickle Cell Anemia  Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Treatment
           3.7.2 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Sickle Cell Anemia  Value Chain Analysis
       4.2. Sickle Cell Anemia  Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Sickle Cell Anemia  Raw Material Manufactures List
           4.2.3. Price Trend of Sickle Cell Anemia  Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL SICKLE CELL ANEMIA  MARKET ANALYSIS BY TREATMENT
       5.1 Overview by Treatment
       5.2 Global Sickle Cell Anemia  Market Analysis by Treatment
       5.3 Market Analysis of Blood Transfusion by Regions
       5.4 Market Analysis of Pharmacotherapy by Regions
       5.5 Market Analysis of Bone Marrow Transplant by Regions
 
6 . GLOBAL SICKLE CELL ANEMIA  MARKET ANALYSIS BY GEOGRAPHY
       6.1. Regional Outlook
       6.2. Introduction
       6.3. North America
           6.3.1. Overview
           6.3.2. North America Sickle Cell Anemia  Market Estimate by Market Segment
           6.3.3. North America Sickle Cell Anemia  Market Estimate by Country
           6.3.4. United State
           6.3.5. Rest of North America
       6.4. Europe
           6.4.1. Overview
           6.4.2. Europe Sickle Cell Anemia  Market Estimate by Market Segment
           6.4.3. Europe Sickle Cell Anemia  Market Estimate by Country
           6.4.4. United Kingdom
           6.4.5. France
           6.4.6. Germany
           6.4.6 Rest of Europe
       6.5. Asia Pacific
           6.5.1. Overview
           6.5.2. Asia Pacific Sickle Cell Anemia  Market Estimate by Market Segment
           6.5.3. Asia Pacific Sickle Cell Anemia  Market Estimate by Country
           6.5.4. China
           6.5.5. Japan
           6.5.6. India
           6.5.6. Rest of Asia Pacific
       6.6. Latin America
           6.6.1. Overview
           6.6.2. Latin America Sickle Cell Anemia  Market Estimate by Market Segment
           6.6.3. Latin America Sickle Cell Anemia  Market Estimate by Country
           6.6.4. Brazil
           6.6.5. Rest of Latin America
       6.7. Middle East & Africa
           6.7.1. Overview
           6.7.2. Middle East & Africa Sickle Cell Anemia  Market Estimate by Market Segment
           6.7.3. Middle East & Africa Sickle Cell Anemia  Market Estimate by Country
           6.7.4. Middle East
           6.7.5. Africa
 
7 . COMPETITIVE LANDSCAPE OF THE SICKLE CELL ANEMIA  COMPANIES
       7.1. Sickle Cell Anemia  Market Competition
       7.2. Partnership/Collaboration/Agreement
       7.3. Merger And Acquisitions
       7.4. New Product Launch
       7.5. Other Developments
 
8 . COMPANY PROFILES OF SICKLE CELL ANEMIA  INDUSTRY
       8.1. Company Share Analysis
       8.2. Market Concentration Rate
       8.3. Bluebird Bio
           8.3.1. Company Overview
           8.3.2. Financials
           8.3.3. Products
           8.3.4. Recent Developments
       8.4. Emmaus Life Sciences
           8.4.1. Company Overview
           8.4.2. Financials
           8.4.3. Products
           8.4.4. Recent Developments
       8.5. Global Blood Therapeutics
           8.5.1. Company Overview
           8.5.2. Financials
           8.5.3. Products
           8.5.4. Recent Developments
       8.6. Novartis
           8.6.1. Company Overview
           8.6.2. Financials
           8.6.3. Products
           8.6.4. Recent Developments
       8.7. Pfizer
           8.7.1. Company Overview
           8.7.2. Financials
           8.7.3. Products
           8.7.4. Recent Developments
 
9.  IMPACT ANALYSIS OF COVID-19 OUTBREAK
       9.1. Impact Analysis of Covid-19 Outbreak on the Market
           9.1.1. Direct Impact on Production
           9.1.2. Supply Chain and Market Disruption
           9.1.3. Financial Impact on Firms and Financial Markets
       9.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       9.3. Pre V/S Post COVID-19 Market
       9.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
       9.5. COVID-19: Micro and Macro Factor Analysis on the Market
    
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers 
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Global Sickle Cell Anemia  Market Analysis in Blood Transfusion by Geography (USD MN)
  • Global Sickle Cell Anemia  Market Analysis in Pharmacotherapy by Geography (USD MN)
  • Global Sickle Cell Anemia  Market Analysis in Bone Marrow Transplant by Geography (USD MN)
  • Global Sickle Cell Anemia  Market by Geography (USD MN)
  • North America Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • North America Sickle Cell Anemia  Market Estimate by Country (USD MN)
  • United State Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Rest of North America Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Europe Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • United Kingdom Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • France Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Germany Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Rest of Europe Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Asia Pacific Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Asia Pacific Sickle Cell Anemia  Market Estimate by Country (USD MN)
  • China Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Japan Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • India Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Rest of Asia Pacific Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Latin America Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Latin America Sickle Cell Anemia  Market Estimate by Country (USD MN)
  • Brazil Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Rest of Latin America Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Middle East & Africa Sickle Cell Anemia  Market Estimate by Treatment (USD MN)
  • Middle East & Africa Sickle Cell Anemia  Market Estimate by Country (USD MN)
  • Middle East Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Africa Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
  • Research Scope of Sickle Cell Anemia  Report
  • Market Research Process
  • Market Research Methodology
  • Global Sickle Cell Anemia  Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Treatment
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Sickle Cell Anemia  Market Analysis by Treatment (USD MN)
  • Global Sickle Cell Anemia  Market Analysis in Blood Transfusion by Geography (USD MN)
  • Global Sickle Cell Anemia  Market Analysis in Pharmacotherapy by Geography (USD MN)
  • Global Sickle Cell Anemia  Market Analysis in Bone Marrow Transplant by Geography (USD MN)
  • Latin America Sickle Cell Anemia  Market by Revenue
  • Middle East & Africa Sickle Cell Anemia  Market by Revenue
  • Recent Development in Sickle Cell Anemia  Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials